JP2013503175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013503175A5 JP2013503175A5 JP2012526951A JP2012526951A JP2013503175A5 JP 2013503175 A5 JP2013503175 A5 JP 2013503175A5 JP 2012526951 A JP2012526951 A JP 2012526951A JP 2012526951 A JP2012526951 A JP 2012526951A JP 2013503175 A5 JP2013503175 A5 JP 2013503175A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- expression level
- sarcoma
- marker
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23684509P | 2009-08-25 | 2009-08-25 | |
| US61/236,845 | 2009-08-25 | ||
| PCT/US2010/046711 WO2011031503A2 (en) | 2009-08-25 | 2010-08-25 | Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015255646A Division JP2016136938A (ja) | 2009-08-25 | 2015-12-28 | エピメタボリックシフター（コエンザイムｑ１０）を使用する肉腫の処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013503175A JP2013503175A (ja) | 2013-01-31 |
| JP2013503175A5 true JP2013503175A5 (enExample) | 2013-10-17 |
| JP6159085B2 JP6159085B2 (ja) | 2017-07-05 |
Family
ID=43730801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012526951A Expired - Fee Related JP6159085B2 (ja) | 2009-08-25 | 2010-08-25 | エピメタボリックシフター（コエンザイムｑ１０）を使用する肉腫の処置方法 |
| JP2015255646A Ceased JP2016136938A (ja) | 2009-08-25 | 2015-12-28 | エピメタボリックシフター（コエンザイムｑ１０）を使用する肉腫の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015255646A Ceased JP2016136938A (ja) | 2009-08-25 | 2015-12-28 | エピメタボリックシフター（コエンザイムｑ１０）を使用する肉腫の処置方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20110064747A1 (enExample) |
| EP (1) | EP2470169A4 (enExample) |
| JP (2) | JP6159085B2 (enExample) |
| KR (1) | KR101572463B1 (enExample) |
| CN (2) | CN108245497A (enExample) |
| AU (2) | AU2010292532A1 (enExample) |
| BR (1) | BR112012004237A8 (enExample) |
| CA (1) | CA2772068C (enExample) |
| CR (1) | CR20120120A (enExample) |
| EA (1) | EA201270325A1 (enExample) |
| IL (1) | IL218306B (enExample) |
| IN (1) | IN2012DN01911A (enExample) |
| MX (1) | MX2012002208A (enExample) |
| SG (2) | SG178547A1 (enExample) |
| WO (1) | WO2011031503A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10519504B2 (en) | 2009-05-11 | 2019-12-31 | Berg Llc | Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| EP2694463B8 (en) | 2011-04-04 | 2019-10-09 | Berg LLC | Treating central nervous system tumors with coenzyme q10 |
| EP2906946A1 (en) | 2012-10-09 | 2015-08-19 | The Procter & Gamble Company | Method of identifying or evaluating beneficial actives and compositions containing the same |
| EP2906197A1 (en) | 2012-10-09 | 2015-08-19 | The Procter & Gamble Company | Method of identifying synergistic cosmetic combinations |
| US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
| US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
| EA032775B1 (ru) | 2013-04-08 | 2019-07-31 | Берг Ллк | Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10 |
| WO2015035094A1 (en) | 2013-09-04 | 2015-03-12 | Berg Llc | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
| US10627392B2 (en) | 2014-06-17 | 2020-04-21 | Stealth Biotherapeutics Corp | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening |
| CN107001451A (zh) * | 2014-07-07 | 2017-08-01 | 阿勒根公司 | 检测组织样品中裂解的snap25的方法 |
| CN105044360A (zh) * | 2015-07-22 | 2015-11-11 | 浙江大学医学院附属邵逸夫医院 | Rbp4作为结直肠癌血清标记物的应用及诊断试剂盒 |
| WO2017087576A1 (en) | 2015-11-16 | 2017-05-26 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
| CN106053813A (zh) * | 2016-06-25 | 2016-10-26 | 林森 | 一种检测鼻咽癌pdk1表达量的免疫组化试剂盒及其应用 |
| CN106947010B (zh) * | 2017-04-06 | 2018-12-11 | 哈尔滨工业大学 | 一种利用光引发raft聚合原位诱导自组装制备蛋白质基纳米粒子的方法 |
| KR102682716B1 (ko) * | 2017-05-17 | 2024-07-08 | 비피지바이오, 인크. | 수포성 표피박리증의 치료 및 예방에서 조효소 q10 제형의 용도 |
| CN107226862A (zh) * | 2017-05-27 | 2017-10-03 | 南京川博生物技术有限公司 | 特异性人ews‑fli1融合蛋白抗体的制备方法及在制备尤文肉瘤诊断抗体试剂的应用 |
| EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
| US20230080670A1 (en) * | 2019-04-05 | 2023-03-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating tumors using transcription inhibition and dna damage |
| JP2024509196A (ja) * | 2021-03-05 | 2024-02-29 | ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド | 癌の治療のためのシャペロニン含有ｔｃｐ－１阻害剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000040749A2 (en) * | 1999-01-06 | 2000-07-13 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
| JP2005522221A (ja) * | 2002-04-17 | 2005-07-28 | ノバルティス アクチエンゲゼルシャフト | チロシンキナーゼ阻害剤に対する患者応答性の予測方法 |
| JP2006345701A (ja) * | 2003-07-01 | 2006-12-28 | Taisho Pharmaceut Co Ltd | タキサン類応答性の判別方法 |
| US20060035981A1 (en) * | 2003-08-02 | 2006-02-16 | Mazzio Elizabeth A | Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment |
| ES2631152T3 (es) * | 2004-01-22 | 2017-08-28 | University Of Miami | Formulaciones de coenzima Q10 tópicas o intravenosas para su uso en el tratamiento del cáncer |
| AU2005245572B9 (en) * | 2004-05-14 | 2009-01-29 | Ludwig Institute For Cancer Research | Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib |
| WO2006125143A2 (en) * | 2005-05-18 | 2006-11-23 | Novartis Ag | Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| CN101297046B (zh) * | 2005-09-02 | 2013-01-02 | 东丽株式会社 | 用于检测尿路上皮癌的试剂盒及方法 |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| EP1991701A4 (en) * | 2006-02-14 | 2010-03-17 | Dana Farber Cancer Inst Inc | COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER |
| US8030013B2 (en) * | 2006-04-14 | 2011-10-04 | Mount Sinai School Of Medicine | Methods and compositions for the diagnosis for early hepatocellular carcinoma |
| WO2009051277A1 (ja) * | 2007-10-18 | 2009-04-23 | Medical Proteoscope Co., Ltd. | 手術後の予後を推定する方法及び診断キット |
-
2010
- 2010-08-25 AU AU2010292532A patent/AU2010292532A1/en not_active Abandoned
- 2010-08-25 US US12/868,678 patent/US20110064747A1/en not_active Abandoned
- 2010-08-25 EA EA201270325A patent/EA201270325A1/ru unknown
- 2010-08-25 KR KR1020127007679A patent/KR101572463B1/ko not_active Expired - Fee Related
- 2010-08-25 SG SG2012012704A patent/SG178547A1/en unknown
- 2010-08-25 BR BR112012004237A patent/BR112012004237A8/pt not_active IP Right Cessation
- 2010-08-25 IN IN1911DEN2012 patent/IN2012DN01911A/en unknown
- 2010-08-25 CA CA2772068A patent/CA2772068C/en not_active Expired - Fee Related
- 2010-08-25 CN CN201711449284.2A patent/CN108245497A/zh active Pending
- 2010-08-25 MX MX2012002208A patent/MX2012002208A/es unknown
- 2010-08-25 EP EP10815861A patent/EP2470169A4/en not_active Withdrawn
- 2010-08-25 WO PCT/US2010/046711 patent/WO2011031503A2/en not_active Ceased
- 2010-08-25 SG SG10201405069QA patent/SG10201405069QA/en unknown
- 2010-08-25 CN CN2010800427577A patent/CN102548549A/zh active Pending
- 2010-08-25 JP JP2012526951A patent/JP6159085B2/ja not_active Expired - Fee Related
-
2012
- 2012-02-23 IL IL218306A patent/IL218306B/en not_active IP Right Cessation
- 2012-03-13 CR CR20120120A patent/CR20120120A/es unknown
-
2013
- 2013-01-24 US US13/749,337 patent/US20130266557A1/en not_active Abandoned
-
2015
- 2015-12-28 JP JP2015255646A patent/JP2016136938A/ja not_active Ceased
-
2016
- 2016-12-23 AU AU2016277749A patent/AU2016277749A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013503175A5 (enExample) | ||
| JP7654769B2 (ja) | 外傷性脳傷害のバイオマーカー | |
| KR102565758B1 (ko) | 암 예후 예측방법 및 이의 조성물 | |
| ES2726650T3 (es) | Métodos de monitorización de terapias inmunosupresoras en un receptor de trasplante | |
| Safarinejad et al. | Glutathione S–transferase polymorphisms (GSTM1, GSTT1, GSTP1) and male factor infertility risk: a pooled analysis of studies | |
| Gashaw et al. | Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4 | |
| WO2016205572A1 (en) | Method and kit for detecting hbv dna | |
| CN101855367A (zh) | 外周血白细胞中FC受体介导的肿瘤坏死因子超家族mRNA表达 | |
| Lacombe et al. | Analysis of saliva gene expression during head and neck cancer radiotherapy: a pilot study | |
| US20140371081A1 (en) | Compositions for and Methods of Detecting, Diagnosing, and Prognosing Thymic Cancer | |
| Shaban et al. | Distribution of glutathione S-transferase omega gene polymorphism with different stages of HBV infection including hepatocellular carcinoma in the Egyptian population | |
| EP2821487B1 (en) | Method for determining presence or absence of cancer cell derived from hepatocellular carcinoma, and determination marker and kit | |
| US20160298198A1 (en) | Method for predicting development of melanoma brain metastasis | |
| GB2486424A (en) | Markers for plasma cell disorders | |
| ES2336928T3 (es) | Metodos de diagnostico y pronostico de esteatohepatitisno alcoholica (ehna). | |
| CN105779465A (zh) | 一种cdkn2a基因片段及其引物以及在肿瘤诊断中的应用 | |
| Højlund et al. | Cell‐free DNA for detection of clonal B cells in diffuse large B cell lymphoma by sequencing | |
| Sessa et al. | Forensic Genetics and Genomic | |
| US20170356048A1 (en) | Method for predicting receptivity to targeted anticancer drug | |
| WO2016133212A1 (ja) | 肝細胞癌に関する診断のために有用な背景肝因子及びその利用 | |
| JP7411988B2 (ja) | Ｈａｍ／ｔｓｐ発症リスク判定方法 | |
| JPWO2011126105A1 (ja) | 免疫系の異常疾患または関節系の異常疾患への罹患またはこれらの病勢を判定するための検査方法 | |
| UA160873U (uk) | Спосіб прогнозування ризику виникнення рецидивів у хворих на рак ендометрія ендометріоїдного типу з початковою стадією | |
| US20130183345A1 (en) | Treatment of Bladder Cancer Following Detection of Expression Levels of Certain Progression Markers | |
| WO2022144485A9 (es) | Biomarcadores y método para predecir o pronosticar la respuesta al tratamiento con inhibidores de braf y de mek (brafi + meki) |